Document is current
Any future updates will be listed below
-
Authors
Tian, Yun
Guo, Jiafan
Mao, Lipeng
Chen, Zhixi
Zhang, Xingwei
Li, Yangqiu
Zhang, Yikai
Zha, Xianfeng
Luo, Oscar Junhong https://orcid.org/0000-0002-1266-3069
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82350610280)
National Natural Science Foundation of China (92370107)
National Natural Science Foundation of China (82293632)
National Natural Science Foundation of China (82400259)
China Postdoctoral Science Foundation (2021M701427)
China Postdoctoral Science Foundation (2013M540685)
Pearl River S and T Nova Program of Guangzhou Municipality (2019QN01Y990)
Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515011034)
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 30 September 2024
First Online: 8 October 2024
Declarations
:
: This study was approved by the Ethics Committee of the School of Medicine, Jinan University (Approval No. [2015] Ethics Approval Section 009). Title of the approved project: Reversal Regulation of TCR VβT Cell Clone Dysfunction Mediated by Immune Checkpoint Receptors in AML. Date of approval: 01 January, 2016.
: The consent for publication was acquired from patients/participants. All authors confirm their consent for publication.
: The authors declare that they have no competing interests.
